Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Sanofi SA (SNY) vs VF Corp (VFC) Price & Performance

Price performance (Past 24H)

Key statistics

Sanofi SA vs VF Corp — how do they compare? Sanofi SA trades at $43.56 (market cap $104.30B), while VF Corp trades at $14.9 (market cap $5.81B). The key difference: Sanofi SA is far larger — about 18× VF Corp's market cap, and Sanofi SA pays the higher dividend (5.55%). Which is the better fit depends on your goals.

SNYVFC
Market Cap
$104.30B$5.81B
Sector
HealthConsumer Cyclical
52-Week High
$52.34$21.55
52-Week Low
$41.33$12.21
Enterprise Value
$124.19B$10.09B
Dividend Yield
5.55%2.44%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Sanofi SA

Sanofi develops and markets drugs with a concentration in oncology, immunology, cardiovascular disease, diabetes, and vaccines. However, the company's decision in late 2019 to pull back from the cardio-metabolic area will likely reduce the firm's footprint in this large therapeutic area. The company offers a diverse array of drugs with its highest revenue generator, Dupixent, representing just over 10% of total sales, but profits are shared with Regeneron. About 30% of total revenue comes from the United States and 25% from Europe. Emerging markets represent the majority of the remainder of revenue.

Read more on SNY

About VF Corp

VF designs, produces, and distributes branded apparel and accessories. Its largest apparel categories include action sports, outdoor, and workwear. Its portfolio of about a dozen brands includes Vans, The North Face, Timberland, Supreme, and Dickies. VF markets its products in the Americas, Europe, and Asia-Pacific through wholesale sales to retailers, e-commerce, and branded stores owned by the company and partners. The company has grown through multiple acquisitions and traces its roots to 1899.

Read more on VFC